Forever Labs: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 26: | Line 26: | ||
{{biotech-stub}} | {{biotech-stub}} | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | |||
Revision as of 17:39, 10 February 2025
Forever Labs is a biotechnology company that specializes in the collection and storage of stem cells for potential future use. The company was founded in 2015 by Steven Clausnitzer and Mark Katakowski, who serve as the CEO and President respectively. Forever Labs is based in Ann Arbor, Michigan, United States.
Overview
Forever Labs offers a service that involves the extraction, processing, and long-term storage of mesenchymal stem cells (MSCs) from the bone marrow of adults. The company's primary goal is to provide a means for individuals to potentially utilize their own stem cells for regenerative medicine therapies in the future.
Procedure
The procedure for collecting stem cells involves a minimally invasive outpatient procedure performed by a board-certified physician. The physician extracts bone marrow from the patient's hip using a special needle. The extracted marrow is then sent to Forever Labs, where the MSCs are isolated, processed, and cryogenically stored.
Potential Applications
The stored MSCs have potential applications in the field of regenerative medicine. They can potentially be used in the future to treat a variety of conditions, including heart disease, diabetes, osteoarthritis, and certain types of cancer. Additionally, MSCs are being researched for their potential use in anti-aging therapies.
Criticism and Controversy
While the concept of storing one's own stem cells for future use is appealing to some, it has also been met with criticism. Some experts argue that the science behind the potential uses of these cells is still in its early stages, and that the benefits of such storage may be overstated.
See Also
References
<references />

This article is a biotechnology stub. You can help WikiMD by expanding it!
